Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) Gastrin-Releasing Peptide Antikörper:
anti-Mouse (Murine) Gastrin-Releasing Peptide Antikörper:
anti-Human Gastrin-Releasing Peptide Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Chicken Polyclonal Gastrin-Releasing Peptide Primary Antibody für IEM, ICC - ABIN617886
Westlund, Lu, Werrbach-Perez, Hulsebosch, Morgan, Pizzo, Eisenberg, Perez-Polo: Effects of nerve growth factor and acetyl-L-carnitine arginyl amide on the human neuronal line HCN-1A. in International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1993
Show all 45 Pubmed References
Human Polyclonal Gastrin-Releasing Peptide Primary Antibody für IHC (fro), IHC (p) - ABIN335197
Gomi, Kikuchi, Adriaensen, Timmermans, De Groodt-Lasseel, Kimura, Naruse, Ishikawa, Kishi, Scheuermann: Immunocytochemical survey of the neuroepithelial endocrine system in the respiratory tract of the Tokyo salamander, Hynobius nebulosus tokyoensis TAgo. in Histochemistry 1995
Show all 2 Pubmed References
Human Polyclonal Gastrin-Releasing Peptide Primary Antibody für EIA, RIA - ABIN613617
Satoh, Takanami, Murata, Kawata, Sakamoto, Sakamoto: Three-dimensional visualization of multiple synapses in thick sections using high-voltage electron microscopy in the rat spinal cord. in Data in brief 2015
Human Polyclonal Gastrin-Releasing Peptide Primary Antibody für - ABIN614009
Takanami, Sakamoto, Matsuda, Satoh, Tanida, Yamada, Inoue, Oti, Sakamoto, Kawata: Distribution of gastrin-releasing peptide in the rat trigeminal and spinal somatosensory systems. in The Journal of comparative neurology 2014
Study finds that the combinatorial expression of gastrin releasing peptide and Neurod6 defines midbrain dopaminergic subpopulations with unique features.
These data suggest that GRPR expression in fibroblast-like synoviocytes (FLS)and that exogenous GRP are able to activate FLS invasion. This effect occurs at least in part through the AKT activation. Therefore, understanding of the GRP/GRPR pathway could be relevant in the development of FLS-targeted therapy for Rheumatoid arthritis .
Both TRPV1 and GRP are part of a new mesoaccumbal glutamatergic pathway.
Fos and phosphorylation of extracellular signal-regulated kinases (ERK) were used to look for evidence that interneurons expressing GRP were activated following intradermal injection of chloroquine.
GrpmRNA and protein are upregulated in dorsal root ganglias, but not in the spinal cord, of mice with chronic itch.
GRP is expressed by a distinct population of excitatory interneurons in laminae I-II that are likely to be involved in the itch pathway
BNP-NPRA signaling is involved in both itch and pain and does not function upstream of the GRP-GRPR dedicated neuronal pathway.
The majority of dorsal spinal cord Grp is synthesized locally in dorsal spinal cord neurons while Nmb is highly expressed in pain- and itch-sensing dorsal root ganglion neurons.
nonamidated peptides derived from the C terminus of pro-GRP are expressed in significant quantities in colorectal cancer cell lines
GRP delays the phase of the clock during the early night by prolonging day-like membrane properties of SCN cells
The GRP receptor system does not mediate kappa opioid receptor antagonist (GNTI)-induced scratching. The kappa opioid system is involved, at least in part, in the scratch suppressing activity of the kappa opioid receptor agonist nalfurafine.
These studies demonstrate that (64)Cu-SarAr-SA-Aoc-bombesin(7-14) and (64)Cu-SarAr-SA-Aoc-GSG-bombesin(7-14) bound with high affinity to GRPR-expressing cells.
A general possible effect of GRP on cortical inhibitory transmission, was shown.
GRP/GRP-R play a transient and non-critical role in intestinal development
GRP has a role in regulation of fear and memory for fear in the mouse amygdala
Potential new role for gastrin-releasing peptide -BB2 signaling within the circadian clock.
New evidence for the occurrence of marked effects of bombesin/gastrin-releasing peptide concerning both the articular chondrocytes and the inflammatory process is obtained in this study
GRP nerve fibers were markedly high in the epidermis of atopic dermatitis mice
GRP may be important both in the endometrial remodeling during the estrous cycle and in the implantation and development of blastocysts
The present results revealed the localization of GRP in the uterine gland cells at light- and electron-microscopic levels and suggested the release of GRP from the cell into the lumen of the gland by exocrine manner.
GRP may be important both in the development of the fetal cervix and secretory activity of the epithelial cells of the cervix.
A panel of three tumor markers CYFRA 21.1, HE4 and ProGRP may play a role for discriminating LC from benign lung disease and subtyping as SCLC.
Pro-GRP is sensitive for SCLC diagnosis. Since high marker levels are related to high disease burden, pro-GRP may have a negative prognostic significance. Follow-up studies are required to define its role in clinical practice in monitoring responses to treatment and early relapses
Altogether, these data show that humanized anti-progastrin antibodies might represent a potential new treatment for K-RAS-mutated colorectal patients, for which there is a crucial unmet medical need
Both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders.
GRP/GRP-R signaling activation contributes to castration-resistant prostate cancer progression
progastrin expression may be predictive of aggressive tumour behaviour in patients with colorectal cancer.
Thus the combination of favourable in vitro and in vivo properties renders BA1 as more potential antagonist bombesin-peptide for targeting GRP-receptor positive tumor. These properties are encouraging to carry out further experiments for non-invasive receptor targeting potential diagnostinc and therapeutic agent for tumors.
serum level not a biomarker in small cell lung cancer
pro-gastrin releasing peptide has a role in promoting the cell proliferation and progression in small cell lung cancer
Our results suggest that, similar to what happens in neutrophils, gastrin-releasing peptide is a migratory, rather than a proliferative, stimulus, for non-small cell lung carcinoma cells, indicating a putative role for gastrin-releasing peptide and gastrin-releasing peptide receptor in metastasis
Serum Pro-GRP was promising biomarker for SCLC diagnosis.
High proGRP expression is associated with poor response to chemotherapy in small cell lung cancer.
CEA, NSE, CA125 and pro-GRP could serve as biomarkers for SCLC, and CEA and CYFRA21-1 could serve as biomarkers for NSCLC. Pro-GRP, CA125 and CEA were related to the clinical stages of lung cancer
Data show that serum neuron-specific enolase, cytokeratin 19 fragment 21-1, pro-gastrin-releasing peptide, squamous cell carcinoma antigen, tissue inhibitor of metalloproteinase-1, and human epididymis protein 4 are not associated with brain metastases.
Our results suggest that progastrin inhibits the acquisition of a M2-phenotype in human macrophages.
No association of 16 GRP and 7 GRPR variants were found with agoraphobia with/without panic disorder.
the role of autophagy in the degradation of gastrin-releasing peptide and subsequent inhibition of angiogenesis
High serum proGRP levels are associated with small-cell lung cancer.
The Gastrin-releasing peptide(GRP)triggers the growth of HepG2 cells through blocking the ER stress-mediated pathway.
GRP silencing decreases anchorage-independent growth, inhibits cell migration and neuroblastoma cell-mediated angiogenesis.
This gene encodes a member of the bombesin-like family of gastrin-releasing peptides. Its preproprotein, following cleavage of a signal peptide, is further processed to produce either the 27 aa gastrin-releasing peptide or the 10 aa neuromedin C. These smaller peptides regulate numerous functions of the gastrointestinal and central nervous systems, including release of gastrointestinal hormones, smooth muscle cell contraction, and epithelial cell proliferation. These peptides are also likely to play a role in human cancers of the lung, colon, stomach, pancreas, breast, and prostate. Alternative splicing results in multiple transcript variants encoding different isoforms.
, proventricular peptide
, neuromedin C
, pre-progastrin releasing peptide